142 related articles for article (PubMed ID: 30643195)
1. ATDC mediates a TP63-regulated basal cancer invasive program.
Palmbos PL; Wang Y; Bankhead Iii A; Kelleher AJ; Wang L; Yang H; Ahmet ML; Gumkowski ER; Welling SD; Magnuson B; Leflein J; Lorenzatti Hiles G; Abel EV; Dziubinski ML; Urs S; Day ML; Ljungman ME; Simeone DM
Oncogene; 2019 May; 38(18):3340-3354. PubMed ID: 30643195
[TBL] [Abstract][Full Text] [Related]
2. ATDC/TRIM29 Drives Invasive Bladder Cancer Formation through miRNA-Mediated and Epigenetic Mechanisms.
Palmbos PL; Wang L; Yang H; Wang Y; Leflein J; Ahmet ML; Wilkinson JE; Kumar-Sinha C; Ney GM; Tomlins SA; Daignault S; Kunju LP; Wu XR; Lotan Y; Liebert M; Ljungman ME; Simeone DM
Cancer Res; 2015 Dec; 75(23):5155-66. PubMed ID: 26471361
[TBL] [Abstract][Full Text] [Related]
3. TRIM29 promotes bladder cancer invasion by regulating the intermediate filament network and focal adhesion.
Palmbos P; Wang Y; Jerome N; Kelleher A; Henderson M; Day M; Coulombe P
Res Sq; 2023 Dec; ():. PubMed ID: 38168254
[TBL] [Abstract][Full Text] [Related]
4. TP63 isoform expression is linked with distinct clinical outcomes in cancer.
Bankhead A; McMaster T; Wang Y; Boonstra PS; Palmbos PL
EBioMedicine; 2020 Jan; 51():102561. PubMed ID: 31927310
[TBL] [Abstract][Full Text] [Related]
5. Upregulated ataxia-telangiectasia group D complementing gene correlates with poor prognosis in patients with esophageal squamous cell carcinoma.
Lai W; Zhao J; Zhang C; Cui D; Lin J; He Y; Zheng H; Wu X; Yang M
Dis Esophagus; 2013; 26(8):817-22. PubMed ID: 23020249
[TBL] [Abstract][Full Text] [Related]
6. The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions.
Yuan Z; Villagra A; Peng L; Coppola D; Glozak M; Sotomayor EM; Chen J; Lane WS; Seto E
Mol Cell Biol; 2010 Jun; 30(12):3004-15. PubMed ID: 20368352
[TBL] [Abstract][Full Text] [Related]
7. ATDC contributes to sustaining the growth and invasion of glioma cells through regulating Wnt/β-catenin signaling.
Cao Y; Shi L; Wang M; Hou J; Wei Y; Du C
Chem Biol Interact; 2019 May; 305():148-155. PubMed ID: 30929997
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-449a functions as a tumor suppressor in pancreatic cancer by the epigenetic regulation of ATDC expression.
Li F; Liang J; Bai L
Biomed Pharmacother; 2018 Jul; 103():782-789. PubMed ID: 29684857
[TBL] [Abstract][Full Text] [Related]
9. ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis.
Wang L; Yang H; Abel EV; Ney GM; Palmbos PL; Bednar F; Zhang Y; Leflein J; Waghray M; Owens S; Wilkinson JE; Prasad J; Ljungman M; Rhim AD; Pasca di Magliano M; Simeone DM
Genes Dev; 2015 Jan; 29(2):171-83. PubMed ID: 25593307
[TBL] [Abstract][Full Text] [Related]
10. ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis.
Wang L; Yang H; Zamperone A; Diolaiti D; Palmbos PL; Abel EV; Purohit V; Dolgalev I; Rhim AD; Ljungman M; Hadju CH; Halbrook CJ; Bar-Sagi D; di Magliano MP; Crawford HC; Simeone DM
Genes Dev; 2019 Jun; 33(11-12):641-655. PubMed ID: 31048544
[TBL] [Abstract][Full Text] [Related]
11. Expression of the ATDC (ataxia telangiectasia group D-complementing) gene in A431 human squamous carcinoma cells.
Laderoute KR; Knapp AM; Green CJ; Sutherland RM; Kapp LN
Int J Cancer; 1996 Jun; 66(6):772-8. PubMed ID: 8647648
[TBL] [Abstract][Full Text] [Related]
12. Down-regulating ATDC inhibits the proliferation of esophageal carcinoma cells.
Lai W; Zheng X; Huang Q; Wu X; Yang M
Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3511-6. PubMed ID: 25491629
[TBL] [Abstract][Full Text] [Related]
13. TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma.
Somerville TDD; Xu Y; Miyabayashi K; Tiriac H; Cleary CR; Maia-Silva D; Milazzo JP; Tuveson DA; Vakoc CR
Cell Rep; 2018 Nov; 25(7):1741-1755.e7. PubMed ID: 30428345
[TBL] [Abstract][Full Text] [Related]
14. ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression.
Papadimitriou MA; Avgeris M; Levis PK; Tokas T; Stravodimos K; Scorilas A
J Cancer Res Clin Oncol; 2019 Dec; 145(12):3075-3087. PubMed ID: 31595333
[TBL] [Abstract][Full Text] [Related]
15. Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer.
Iyyanki T; Zhang B; Wang Q; Hou Y; Jin Q; Xu J; Yang H; Liu T; Wang X; Song F; Luan Y; Yamashita H; Chien R; Lyu H; Zhang L; Wang L; Warrick J; Raman JD; Meeks JJ; DeGraff DJ; Yue F
Genome Biol; 2021 Apr; 22(1):105. PubMed ID: 33858483
[TBL] [Abstract][Full Text] [Related]
16. Suppression of anchorage-independent growth by expression of the ataxia-telangiectasia group D complementing gene, ATDC.
Hosoi Y; Kapp LN; Murnane JP; Matsumoto Y; Enomoto A; Ono T; Miyagawa K
Biochem Biophys Res Commun; 2006 Sep; 348(2):728-34. PubMed ID: 16890201
[TBL] [Abstract][Full Text] [Related]
17. NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinoma.
Hegde GV; de la Cruz C; Giltnane JM; Crocker L; Venkatanarayan A; Schaefer G; Dunlap D; Hoeck JD; Piskol R; Gnad F; Modrusan Z; de Sauvage FJ; Siebel CW; Jackson EL
Elife; 2019 May; 8():. PubMed ID: 31144617
[TBL] [Abstract][Full Text] [Related]
18. ΔNp63α induces the expression of FAT2 and Slug to promote tumor invasion.
Dang TT; Westcott JM; Maine EA; Kanchwala M; Xing C; Pearson GW
Oncotarget; 2016 May; 7(19):28592-611. PubMed ID: 27081041
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 9 (HDAC9) regulates the functions of the ATDC (TRIM29) protein.
Yuan Z; Peng L; Radhakrishnan R; Seto E
J Biol Chem; 2010 Dec; 285(50):39329-38. PubMed ID: 20947501
[TBL] [Abstract][Full Text] [Related]
20. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
